Marcourakis T

Department of Clinical and Toxicological Analyses, University of Sao Paulo, Sao Paulo, Brazil.

6 papers · 1 preprint

ArticleAyahuasca

Predicting drug-drug interactions between ayahuasca alkaloids and SSRIs using physiologically based pharmacokinetic modeling.

Ribeiro GSG, Paranhos BAPB, Dörr F +11

Europe PMC2026
ArticleAyahuasca

Dimethyltryptamine and harmine, components of ayahuasca, prevented cocaine-induced apoptosis in SH-SY5Y human neuroblastoma cells.

Salles G, Almeida CAF, de Carvalho Alves I +11

Europe PMC2026
ArticleAyahuasca

Ayahuasca prevents the reinstatement of cocaine-induced rewarding effects in C57Bl/6 mice.

Bruno V, Spelta LEW, Pereira ML +9

Europe PMC2025
ArticlePsilocybin

High dose of psilocybin induces acute behavioral changes without inducing conditioned place preference in Sprague-Dawley rats.

Bruno V, López-Canul M, Richardson B +3

Europe PMC2026
PreprintAyahuasca

Ayahuasca prevents the reinstatement of cocaine-induced rewarding effects in C57Bl/6 mice

Bruno V, Spelta LEW, Pereira ML +9

Europe PMC2025
ArticleAyahuasca

Ayahuasca for the treatment of alcohol use disorder.

Marinho EAV, Serra YA, Oliveira-Lima AJ +2

Europe PMC2024
ArticleAyahuasca

Ayahuasca, a psychedelic beverage, modulates neuroplasticity induced by ethanol in mice.

Almeida CAF, Pereira-Junior AA, Rangel JG +10

Europe PMC2022